R.M. Sincerbeaux Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,100
| Closed | -$1.6M | – | 39 |
|
|
2025
Q3 | $1.6M | Buy |
+2,100
| New | +$1.56M | 0.86% | 25 |
|
|
2025
Q1 | – | Sell |
-2,100
| Closed | -$1.62M | – | 40 |
|
|
2024
Q4 | $1.62M | Buy |
+2,100
| New | +$1.74M | 0.97% | 24 |
|
|
2023
Q3 | – | Sell |
-6,200
| Closed | -$2.91M | – | 42 |
|
|
2023
Q2 | $2.91M | Hold |
6,200
| – | – | 1.99% | 15 |
|
|
2023
Q1 | $2.13M | Hold |
6,200
| – | – | 1.48% | 21 |
|
|
2022
Q4 | $2.27M | Hold |
6,200
| – | – | 1.61% | 20 |
|
|
2022
Q3 | $2M | Hold |
6,200
| – | – | 1.58% | 20 |
|
|
2022
Q2 | $2.01M | Hold |
6,200
| – | – | 1.47% | 21 |
|
|
2022
Q1 | $1.77M | Hold |
6,200
| – | – | 1.12% | 24 |
|
|
2021
Q4 | $1.71M | Buy |
6,200
+1,000
| +19% | +$254K | 1.03% | 25 |
|
|
2021
Q3 | $1.2M | Sell |
5,200
-1,000
| -16% | -$247K | 0.79% | 30 |
|
|
2021
Q2 | $1.42M | Hold |
6,200
| – | – | 0.9% | 28 |
|
|
2021
Q1 | $1.16M | Hold |
6,200
| – | – | 0.79% | 29 |
|
|
2020
Q4 | $1.05M | Hold |
6,200
| – | – | 0.76% | 30 |
|
|
2020
Q3 | $918K | Hold |
6,200
| – | – | 0.78% | 28 |
|
|
2020
Q2 | $1.02M | Hold |
6,200
| – | – | 0.91% | 27 |
|
|
2020
Q1 | $860K | Hold |
6,200
| – | – | 0.85% | 28 |
|
|
2019
Q4 | $815K | Hold |
6,200
| – | – | 0.63% | 31 |
|
|
2019
Q3 | $693K | Hold |
6,200
| – | – | 0.55% | 32 |
|
|
2019
Q2 | $687K | Hold |
6,200
| – | – | 0.56% | 31 |
|
|
2019
Q1 | $805K | Hold |
6,200
| – | – | 0.65% | 30 |
|
|
2018
Q4 | $717K | Hold |
6,200
| – | – | 0.66% | 30 |
|
|
2018
Q3 | $665K | Hold |
6,200
| – | – | 0.54% | 34 |
|
|
2018
Q2 | $529K | Hold |
6,200
| – | – | 0.47% | 37 |
|
|
2018
Q1 | $480K | Hold |
6,200
| – | – | 0.45% | 35 |
|
|
2017
Q4 | $524K | Hold |
6,200
| – | – | 0.48% | 35 |
|
|
2017
Q3 | $530K | Hold |
6,200
| – | – | 0.51% | 36 |
|
|
2017
Q2 | $510K | Hold |
6,200
| – | – | 0.46% | 39 |
|
|
2017
Q1 | $521K | Hold |
6,200
| – | – | 0.48% | 39 |
|
|
2016
Q4 | $456K | Hold |
6,200
| – | – | 0.43% | 40 |
|
|
2016
Q3 | $498K | Hold |
6,200
| – | – | 0.49% | 39 |
|
|
2016
Q2 | $488K | Hold |
6,200
| – | – | 0.5% | 40 |
|
|
2016
Q1 | $446K | Hold |
6,200
| – | – | 0.47% | 43 |
|
|
2015
Q4 | $522K | Hold |
6,200
| – | – | 0.57% | 38 |
|
|
2015
Q3 | $519K | Hold |
6,200
| – | – | 0.55% | 38 |
|
|
2015
Q2 | $518K | Hold |
6,200
| – | – | 0.51% | 38 |
|
|
2015
Q1 | $450K | Hold |
6,200
| – | – | 0.41% | 41 |
|
|
2014
Q4 | $428K | Sell |
6,200
-302
| -5% | -$20.4K | 0.39% | 43 |
|
|
2014
Q3 | $422K | Hold |
6,502
| – | – | 0.39% | 45 |
|
|
2014
Q2 | $404K | Hold |
6,502
| – | – | 0.38% | 46 |
|
|
2014
Q1 | $383K | Hold |
6,502
| – | – | 0.38% | 47 |
|
|
2013
Q4 | $332K | Buy |
+6,502
| New | +$326K | 0.33% | 48 |
|
Other funds holding LLY
R.M. Sincerbeaux Capital Management's LLY Position: Q4 2025 in Review
R.M. Sincerbeaux Capital Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 2,100 shares — an estimated $1.6M sold.
R.M. Sincerbeaux Capital Management first reported a position in LLY in Q4 2013 and held it in 41 quarters. The position peaked at $2.91M in Q2 2023. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- R.M. Sincerbeaux Capital Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
- R.M. Sincerbeaux Capital Management sold 2,100 Eli Lilly shares in Q4 2025, an estimated $1.6M.
- R.M. Sincerbeaux Capital Management first reported a position in Eli Lilly in Q4 2013 and held it in 41 quarters.
- R.M. Sincerbeaux Capital Management's Eli Lilly position peaked at $2.91M in Q2 2023.
- 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on R.M. Sincerbeaux Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.